Exceeding Financial Guidance
Net revenue for the full year reached $334 million and adjusted EBITDA was $12.3 million, both exceeding guidance. Operating expenses were reduced by over $30 million, reflecting strong financial discipline.
Consumable Sales Growth
Consumable sales grew 8.7% in Q4 compared to the previous year, with full-year sales reaching $208.9 million, marking a 10.1% increase in the Americas, 5.3% in APAC, and 8.2% in EMEA.
Operational Improvements
Consolidated manufacturing in Long Beach, exited China production, and completed the Syndeo 3.0 global replacement program, improving quality control and gross margin profile.
Innovation and Product Pipeline
Launched the Hydralock HA Booster, the most successful Hydrafacial branded booster to date, and plans to release additional boosters in 2025.